Security key
918385204
vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT)
CUSIP: 918385204
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Class A Common Stock, par value $0.01 per share
- Shares outstanding
- 3,948,649
- Total 13F shares
- 587,143
- Share change
- +15,431
- Total reported value
- $8,742,344
- Price per share
- $15.00
- Number of holders
- 21
- Value change
- +$226,154
- Number of buys
- 9
- Number of sells
- 5
Report period
Q2 2025
Institutions
21
Top holders
10
VTVT full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
vTv Therapeutics Inc. SEC filings
vTv Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 918385204
Recent filing periods:
Top shareholders of VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Ronald O Perelman |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
36,519,212
|
$30,482,586 | — | 20 Dec 2021 | |
| Deepa Prasad |
3/4/5
|
President and CEO, Director |
—
class O/S missing
|
2,498,635
|
$29,508,879 | — | 19 Oct 2021 | |
| Samsara BioCapital GP, LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
1,099,362
mixed-class rows
|
$14,038,836 | — | 05 Mar 2024 | |
| Rich S. Nelson |
3/4/5
|
Acting Chief Executive Officer, Director |
—
class O/S missing
|
500,000
|
$5,905,000 | — | 03 Mar 2022 | |
| Samsara BioCapital, LLC |
13F
|
Company |
5.2%
|
206,784
|
$3,581,499 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
4.5%
|
178,200
|
$3,086,424 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.5%
|
97,314
|
$1,685,478 | — | 31 Mar 2025 | |
| Chandresh Harjivan |
3/4/5
|
Director |
—
class O/S missing
|
75,000
|
$1,203,000 | — | 19 Jun 2023 | |
| Hersh Kozlov |
3/4/5
|
Director |
—
class O/S missing
|
75,000
|
$1,203,000 | — | 19 Jun 2023 | |
| Howard L. Weiner |
3/4/5
|
Director |
—
class O/S missing
|
75,000
|
$1,203,000 | — | 19 Jun 2023 | |
| John A. Fry |
3/4/5
|
Director |
—
class O/S missing
|
75,000
|
$1,203,000 | — | 19 Jun 2023 | |
| Keith R. Harris |
3/4/5
|
Director |
—
class O/S missing
|
75,000
|
$1,203,000 | — | 19 Jun 2023 | |
| Steven L. Tuch |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
74,659
|
$881,723 | — | 27 Feb 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
41,558
|
$719,784 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.4%
|
15,626
|
$270,642 | — | 31 Mar 2025 | |
| Fahed Al-Marzooqi |
3/4/5
|
Director |
—
class O/S missing
|
13,555
|
$224,877 | — | 10 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
12,637
|
$218,918 | — | 31 Mar 2025 | |
| Anne M. Phillips |
3/4/5
|
Director |
—
class O/S missing
|
10,860
|
$180,167 | — | 10 Jun 2025 | |
| Daniel K. Spiegelman |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
$165,900 | — | 10 Jun 2025 | |
| Connective Capital Management, LLC |
13F
|
Company |
0.24%
|
9,377
|
$162,410 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.12%
|
4,704
|
$81,473 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.1%
|
4,040
|
$69,973 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
746
|
$12,921 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
394
|
$6,824 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
152
|
$2,632 | — | 31 Mar 2025 | |
| Activest Wealth Management |
13F
|
Company |
0%
|
50
|
$866 | — | 31 Mar 2025 | |
| CoreCap Advisors, LLC |
13F
|
Company |
0%
|
45
|
$779 | — | 31 Mar 2025 | |
| Parallel Advisors, LLC |
13F
|
Company |
0%
|
38
|
$658 | — | 31 Mar 2025 | |
| Sunbelt Securities, Inc. |
13F
|
Company |
0%
|
15
|
$260 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
10
|
$173 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
10
|
$173 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
9
|
$156 | — | 31 Mar 2025 | |
| Barry K. Brown |
3/4/5
|
Chief Accounting Officer |
—
class O/S missing
|
4
|
$68 | — | 11 Apr 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
3
|
$52 | — | 31 Mar 2025 | |
| G42 Investments AI Holdings RSC Ltd. |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
10,386,274
|
— | — | 31 May 2022 | |
| Hh Sheikh Tahnoon bin Zayed S. Al-Nahyan |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
10,386,274
|
— | — | 31 May 2022 |
Institutional Holders of vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) as of Q2 2025
As of 30 Jun 2025,
vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
587,143 shares.
The largest 10 holders included
SAMSARA BIOCAPITAL, LLC, FMR LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, NORTHERN TRUST CORP, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Connective Capital Management, LLC, BlackRock, Inc., and UBS Group AG.
This page lists
21
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
20
Q2 2025 holders
21
Holder diff
1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.